The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: Current status and novel approaches

British Journal of Haematology

Volumn 107, Issue 3, 1999, Pages 485-493

  Richardson, Paul ^a,b   Guinan, Eva ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Diagnosis; Hepatic VOD; Pathology; Treatment

Indexed keywords

DEFIBROTIDE; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; URSODEOXYCHOLIC ACID;

CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; LIVER VENOOCCLUSIVE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEPSIS; VIRUS INFECTION;

EID: 0032722869     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01680.x     Document Type: Review

References (86)

1. Abecasis, M., Ferreira, I., Guimaracs, A. & Machado, A. (1999) Defibrotide as salvage therapy for hepatic veno-occlusive disease (VOD). (Abstract). Bone Marrow Transplantation, 23, 749.
2. Anscher, M.S., Peters, W.P., Reisenbichler, H., Petros, W.P., Jirtle, R.L. (1993) TGF-b as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. New England Journal of Medicine, 328, 1592-1598.
3. Bandini, G., Belardinelli, A., Rosti, G., Calori, E., Motta, M.R., Rizzi, S., Benini, C. & Tura, S. (1994) Toxicity of high-dose busulphan and cyclophosphamide as conditioning therapy for allogeneic bone marrow transplantation in adults with hematological malignancies. Bone Marrow Transplantatian, 13, 577-581.
4. Bearman, S.I. (1995) The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood, 85, 3005-3020.
5. Bearman, S.I., Anderson, G.L., Mori, M., Hinds, M.S., Shulman, H.M. & McDonald, G.B. (1993a) Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. Journal of Clinical Oncology, 11, 1729-1736.
6. Bearman, S.I., Lee, J.L., Baron, A.E. & McDonald, G.B. (1997) Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood, 89, 1501-1506.
7. Bearman, S.I., Shen, D., Hinds, M.S., Hill, H. & McDonald, G.B. (1993b) A phase 1/2 study of prostaglandin El for the prevention of hepatic venocclusive disease after bone marrow transplantation. British Journal of Haematology, 84, 724-730.
8. Bearman, S.I., Shuhart, M.C., Hinds, M.S. & McDonald, G.B. (1992) Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation. Blood, 80, 2458-2462.
9. Berti, F., Rossoni, G., Biasi, G., Buschi, A. & Mandelli, V. (1990) Defibrotide by enhancing prostacyclin generation prevents endothelin-I induced contraction in human saphenous veins. Prostaglandins, 40, 337-350.
10. Bianchi, G., Barone, D., Lanzarotti, E., Tettamanti, R., Porta, R., Moltrasio, D., Cedro, A., Salvetti, L., Mantovani, M. & Prino, G. (1993) Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. European Journal of Pharmacology, 238, 327-334.
11. Bianchi, M. & Tracey, K.J. (1994) The role of TNF in complications of marrow transplantation. Marrow Transplantation Reviews, 3, 57-61.
12. Bonomini, V., Frasca, G.M., Raimondi, C., D'arcangelo, G.L. & Vangelista, A. (1985) Effect of a new antithrombotic agent (Defibrotide) in acute renal failure due to thrombotic microangiopathy. Nephron, 40, 195-200.
13. Bonomini, V., Vangelista, A. & Frasca, G.M. (1984) A new antithrombotic agent in the treatment of acute renal failure due to hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura. (Letter). Nephron, 37, 144.
14. Bracht, F. & Schror, K. (1994) Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro. Biochemical and Biophysical Research Communications, 200, 933-936.
15. Brown, B.P., Abu-Yousef, M., Farner, R., LaBrecque, D. & Gingrich, R. (1990) Doppler sonography: A noninvasive method for evaluation of hepatic venocclusive disease. American Journal of Radiology, 154, 721-724.
16. Budinger, M.D., Bouvier, M., Shah, A. & McDonald, G.B. (1996) Results of a phase 1 trial of antithrombin III as prophylaxis in bone marrow transplant patients at risk for venocclusive disease. (Abstract). Blood, 88, 172a.
17. Carreras, E., Bertz, H., Arcese, W., Vernant, J.-P., Tomas. J.-F., Hagglund, H., Bandini, G., Esperou, H., Russell, J., Rubia, J., Girolamo, G., Demuynck, H., Hartmann, O., Clausen, J., Ruutu, T., Leblond, V., Iriondo, A., Bosi, A., Ben-Bassat, I., Koza, V., Gratwohl, A. & Apperley, J.F. (1998) Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood, 92, 3599-3604.
18. Carreras, E., Granena, A., Navasa, M., Bruguera, M., Marco, V., Sierra, J., Tassies, M.D., Garcia-Pagan, J.C., Marti, J.M. & Bosch, J. (1993) Transjugular liver biopsy in bone marrow transplantation. Bone Marrow Transplant, 11, 21-26.
19. Catuni, L., Gugliotta, L., Vianelli, N., Nocentini, F., Baravelli, S., Bandini, G., Cirio, T.M. & Tura, S. (1996) Endothelium and bone marrow transplantation. Bone Marrow Transplantation, 17, 277-280.
20. Christians, U., Spiekermann, K., Bader, A., Schottmann, R., Linck, A., Wnigeit, K., Sewing, K.F. & Link, H. (1993) Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMT. Bone Marrow Transplant, 12, 27-33.
21. Clift, R.A., Bianco, J.A., Appelbaum, F.R., Buckner, C.D., Singer, J.W., Bakke, L., Bensinger, W.I., Bowden, R.A., McDonald, G.B. & Schubert, M. (1993) A randomised controlled trial of pentoxyfylline for the prevention of regimen-related toxicities in patients undergoing allogeneic transplantation. Blood, 82, 2025-2030.
22. Coccheri, S. & Biagi, G. (1991) Defibrotide. Cardiovascular Drug Review, 9, 172-196.
23. Coccheri, S., Biagi, G., Legnani, C., Bianchini, B. & Grauso, F. (1988) Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man. European Journal of Clinical Pharmacology. 35, 151-156.
24. DeLeve, L.D. (1996) Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation. Hepatology, 24, 830-837.
25. Eltumi, M., Trivedi, P., Hobbs, J.R., Portmann, B., Cheeseman, P., Downie, C., Risteli, L. & Mowat, A.P. (1993) Monitoring of venoocclusive disease after bone marrow transplantation by serum aminopropepide of type III procollagen. Lancet, 342, 518-521.
26. Essell, J.H., Schroeder, M.T., Harman, G.S., Halvorson, R., Lew, V., Callander, N., Snyder, M., Lewis, S.K., Allerton, J.P. & Thompson, J.M. (1998) Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. Annals of Internal Medicine, 128, 975-981.
27. Faioni, E.M., Krachmalnicoff, A., Bearman, S.I., Federici, A.B., Decarli, A., Gianni, A.M., McDonald, G.B. & Mannucci, P.M. (1993) Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. Blood, 81, 3458-3462.
28. Fareed, J. (1997) Modulation of endothelium by heparin and related polyelectrolytes. In: Advances in Vascular Pathology 1997 (ed. by A. Nicolaides and S. Novo). Elsevier Science BV, Amsterdam.
29. Ferra, C., Sanjose, S., Lastra, C.F., Marti, F., Marino, E.L., Sureda, A., Brunet, S., Gallardo, D., Berlanga, J.J., Garcia, J. & Granena, A. (1997) Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplantation, 20, 1075-1080.
30. Fink, J., Cooper, M., Burkhart, K., McDonald, G.B. & Zager, R.A. (1995) Marked enzymuria following bone marrow transplantation: a correlate of veno-occlusive disease-induced 'hepato-renal syndrome'. Journal of American Society for Nephrology, 6, 1655 1660.
31. Fried, M.W., Connaghan, D.G., Sharma, S., Martin, L.G., Devine, S., Holland, K., Zuckerman, A., Kaufman, S., Wingard, J. & Boyer, T.D. (1996) Transjugular intrahepatic prosystemic shunt for the management of severe venocclusive disease following bone marrow transplantation. Hepatology, 24, 588-591.
32. Goringe, A.P., Brown, S., O'Callaghan, U., Rees, J., Jebb, S., Elia, M. & Poynton, C.H. (1998) Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high dose chemotherapy. Bone Marrow Transplantation, 21, 829-832.
33. Grochow, L.B. (1995) Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens. Seminars in Oncology, 20, 18-25.
34. Hagglund, IL., Remberger, M., Klaesson, S., Lonnqvist, B., Ljungman, P. & Ringden, O. (1998) Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. Blood, 92, 4568-4572.
35. Haire, W.D., Ruby, E.I., Gordon, B.G., Patil, K.D., Stephens, L.C., Kotulak, G.D., Reed, E.C., Vose, J.M., Bierman, P.J., Kessinger, A. & Armitage, J.O. (1995) Multiple: organ dysfunction syndrome in bone marrow transplantation. Journal of the American Medical Association, 274, 1289-1295.
36. Haire, W.D., Stephens, L.C. & Ruby, E.I. (1996) Antithrombin III (AT3) treatment of organ dysfunction during bone marrow transplantation (BMT): results of a pilot study. (Abstract). Blood, 88, 458a.
37. Hosoki, T., Kuroda, C., Tokunaga, K., Marukawa, T., Masuike, M. & Kozuka, T. (1989) Hepatic venous outflow obstruction: evaluation with pulsed duplex sonography. Radiology, 170, 733-737.
38. Ibrahim, A., Pico, J.L., Maraninchi, D., Zambon, E., Attal, M., Brault, P., Tilly, H., Blase, D. & Hayat, M. (1991) Hepatic venocclusive disease following bone marrow transplantation treated by prostaglandin El. (Abstract). Bone Marrow Transplantation. 7, 53.
39. Jones, R.J., Lee, K.S.K., Beschorner, W.E., Vogel, V.G., Grochow, L.B., Braine, H.G., Vogelsang, G.B., Sensenbrenner, L.L., Santos, G.W. & Saral, R. (1987) Venoocclusive disease of the liver following bone marrow transplantation. Transplantation, 44, 778-783.
40. Kami, M., Mori, S., Tanikuwa, H., Akiyama, H., Onozawa, Y., Tanaka, T., Okamoto, R., Maeda, Y., Sasaki, T., Kaku, IL., Matsuura, Y., Hiruma, K. & Sakamaki, H. (1997) Risk factors for hepatic veno-occlusive disease after bone transplantation: retrospective analysis of 137 cases at a single institution. Bone Marrow Transplantation, 20, 397-402.
41. Khoury, H., Adkins, D., Trinkaus, K., Brown, R., Westervelt, P., Vij, R., Goodnough, L.T. & Di Persio, J.F. (1998) Treatment of hepatic veno-occlusive disease with high dose corticosteroids: an update on 28 stem cell transplant recipients. (Abstract). Blood, 92, 1132.
42. Leahey, A.M. & Bunin, N.J. (1996) Recombinant human tissue plasminogen activator for the treatment of severe hepatic venoocclusive disease in pediatric bone marrow transplant patients. Bone Marrow Transplantation, 17, 1101-1104.
43. Lee, J.L., Gooley, T., Bensinger, W., Schiffman, K. & McDonald, G.B. (1997) Venocclusive disease of the liver after high-dose chemotherapy with alkylating agents: incidence, outcome and risk factors. Hepatology, 26, 149A.
44. McDonald, G.B. (1993) Venocclusive disease of the liver following marrow transplantation. Marrow Transplantation Reviews, 3, 49-56.
45. McDonald, G.B., Hinds, M.S., Fisher, L.D., Schoch, H.G., Wolford, J.L., Banaji, M., Hardin, B.J., Shulman, H.M. & Clift, R.A. (1993) Venoocclusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Annals of Internal Medicine, 118, 255-267.
46. McDonald, G.B., Sharma, P., Matthews, D.E., Shulman, H.M. & Thomas, E.D. (1984) Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors. Hepatology, 4, 116-122.
47. McDonald, G.B., Shulman, H.M., Wolford, J.L., & Spencer, G.D. (1987) Liver disease after human marrow transplantation. Seminars in Liver Disease, 7, 210-229.
48. Morris, J.D., Harris, R.E., Hashmi, R., Sambrano, J.E., Gruppo, R.A., Becker, A.T. & Morris, C.L. (1997) Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation. Bone Marrow Transplantation, 20, 871-878.
49. Nicolau, C., Concepcio, B., Carreras, E., Bosch, J., Bianchi, L., Gilabert, R. & Vilana, R. (1993) Sonographic diagnosis and hemodynamic correlation in veno-occlusive disease of the liver, Journal of Ultrasound Medicine, 12, 437-440.
50. Or, R., Nagler, A., Shpilberg, O., Elad, S., Naparstek, E., Kapelushnik, J., Cass, Y., Gillis, S., Chetrit, A., Slavin, S. & Eldor, A. (1996) Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. Transplantation, 61, 1067-1071.
51. Palmer, K.J. & Goa, K.L. (1993) Defibrotide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs, 45, 259-294.
52. Park, Y.-D., Yasui, M., Yoshimoto, T., Chayama, K., Shimono, T., Inoue, M., Yumura-Yagi, K. & Kawa-Ha, K. (1997) Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation. Bone Marrow Transplantation, 11, 471-472.
53. Radich, J.P., Sanders, J.E., Buckner, C.D., Martin, P.J., Peterson, F.B., Bensinger, W., McDonald, G.B., Mori, M., Schoch, G. & Hansen, J.A. (1993) Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with TBI-containig regimens. Journal of Clinical Oncology, 11, 304-313.
54. Richardson, P., Hoppensteadt, D., Elias, A., Frei III, E., Iacobelli, M., Guinan, E. & Fareed, J. (1997) Elevation of tissue factor pathway inhibitor [TFPI]. thrombomodulin [TM] and plasminogen activator inhibitor-1 [PAI-1] levels in stem cell transplant [SCT]-associated veno-occlusive disease [VOD] and changes seen with the use of defibrotide [DF]. Blood, 90, 219a.
55. Richardson, P., Krishnan, A., Wheeler, C., Hoppensteadt, D., Tuchin, J., Fyfe, H., Bierer, B., Guinan, E., Antin, J., Frei, E., III, Fareed, J. & Elias, A. (1996) Elevation of PAI-1 levels in BMT-assodated VOD and changes seen with the use of defibrotide. Blood, 88, 458a.
56. Richardson, P.G., Elias, A.D., Krishnan, A., Wheeler, C., Nath, R., Hoppensteadt, D., Kinchla, N.M., Neuberg. D., Wader, E.K., Antin, J.H., Soiffer, R., Vredenburgh, J., Lill, M., Woolfrey, A.E., Bearman, S.I., Iacobelli, M., Fareed, J. & Guinan, E.C. (1998) Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood, 92, 737-744.
57. Ringden, O., Ruutu, T., Remberger, M., Nickoskelainen, J., Volin, L., Parkkali, T., Lenhjoff, S., Sauerfors, B. & Ljungman, P. (1994) A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood, 83, 2723-2730.
58. Rio, B., Andreu, G., Nicod, A., Arago, J.P., Dutrillaux, F., Samama, M. & Zittoun, R. (1986) Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy. Blood, 67, 1773-1776.
59. Rosenthal, J., Sender, L., Secola, R., Killen, R., Millerick, M., Murphy, L. & Cairo, M.S. (1996) Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation. Bone Marrow Transplantation, 18, 185-191.
60. Rubenfeld, G.D. & Crawford, S.W. (1996) Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Annals of Internal Medicine, 125, 625-633.
61. Ruutu, T., Eriksson, B., Remes, K., Vilin, L., Remberger, M., Parkkali, T., Juvoner, E. & Ringden, O. (1999) Ursodiol for the prevention of hepatic complications in allogeneic stem cell transplantation. (Abstract). Bone Marrow Transplantation, 23, 756.
62. Salat, C., Holler, E., Hans-Jochem, K., Brigitte, R., Pihusch, R., Wolfgang, W. & Hiller, E. (1997) Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplant. Blood, 89, 2184-2188.
63. Salat, C., Holler, E., Reinhardt, B., Kolb, H.J., Seeber, B., Ledderose, G., Mittermueller, J., Duell, T., Wilmanns, W. & Hiller, E. (1994) Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplantation, 14, 747-750.
64. Salat, C., Pihusch, R., Fries, S., Göhring. P., Muth, A., Schlevning, M., Schmid, C., Diem, H., Hiller, E. & Kolb, H.J. (1999) Successful treatment of veno-occlusive disease with defibrotide: a report of two cases. (Abstract). Bone Marrow Transplantation, 23, 757.
65. Schlitt, H.J., Tischler, H.J., Ringe, B., Raddatz, G., Maschek, H., Dietrich, H., Kuse, E., Pichlmayr, R. & Link, H. (1995) Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation: clinical and immunological considerations. Bone Marrow Transplantation, 16, 473-478.
66. Schuler, U., Schroer, S., Kuhnle, A., Blanz, J., Mewes, K., Kumbier, I., Proksch, B., Zeller, K..-P & Ehninger, G. (1994) Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted? Bone Marrow Transplantation, 14, 759-765.
67. Schuler, U.S., Ehrsam, M., Schneider, A., Schmidt, H., Deeg, J. & Ehninger, G. (1998) Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for hematopoietic stem cell transplantation. Bone Marrow Transplantation, 22, 241-244.
68. Scrobohaci, M.L., Drouet, L., Monem-Mansi, A., Devergie, A., Baudin, B., D'Agay, M.F. & Gluckman, E. (1991) Liver venoocclusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thrombosis Research, 63, 509-519.
69. Shirai, M., Nagashima, K., Iwasaki, S. & Mori, W. (1987) A light and scanning electron microscopic study of hepatic veno-occlusive disease. Acta Pathologica Japonica, 37, 1961-1971.
70. Shulman, H.M., Fisher, L.B., Schoch, H.G., Kenne, K.W. & McDonald, G.B. (1994) Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology, 19, 1171-1180.
71. Shulman, H.M., Gooley, T., Dudley, M.D., Kofler, T., Feldman, R., Dwyer, D. & McDonald, G.B. (1995) Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation, 59, 1015-1022.
72. Shulman, H.M., Gown, A.M. & Nugent, D.J. (1987) Hepatic venoocclusive disease after bone marrow transplantation: immuno-histochemical identification of the material within occluded central venules. American Journal of Pathology, 127, 549-558.
73. Shulman, H.M., McDonald, G.B., Matthews, D., Doney, K.C., Kopecky, K.J., Gauvreau, J.M. & Thomas, E.D. (1980) An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology, 79, 1178-1191.
74. Slattery, J.T., Kalhorn, T.F., McDonald, G.B., Lambert, K., Buckner, C.D., Bensinger, W.I., Anasetti, C. & Appelbaum, F.R. (1996) Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients. Journal of Clinical Oncology, 14, 1484-1494.
75. Smith, F.O., Johnson, M.S., Scherer, L.R., Faught, P., Breitfeld, P.P., Allbright, E., Hillier, S.C., Gowan, D., Smith, P.D., Robertson, K.A. & Emanuel, D. (1996) Transjugular intrahepatic portosystemic shunting (TIPS) for the treatment of severe hepatic veno-occlusive disease. Bone Morrow Transplantation, 18, 643-646.
76. Sonneveld, P., Lameris, J.S., Cornelissen, J., Ogilvie, A. & Lowenberg, B. (1998) Color-flow imaging sonography of portal and hepatic vein flow to monitor fibrinolytic therapy with r-TPA for venoocclusive disease following myeloablative treatment. Bone Marrow Transplantation, 21, 731-734.
77. Stockschlaeder, M., Storb, R., Pepe, M., Longton, G., McDonald, G., Anasetti, C., Appelbaum, F., Doney, K., Martin, P. & Sullivan, K. (1992) A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation. British Journal of Haematology, 80, 49-54.
78. Strasser, S. & McDonald, G. (1998) Gastrointestinal and hepatic complications. Hematopoietic Cell Transplantation (ed. by S. Forman, K. Blume and E. Thomas), Chapter 56, pp. 1-127. Blackwell Science, Oxford.
79. Teicher, B.A., Crawford, J.M., Holden, S.A., Lin, Y., Cathcart, K.N.S., Luchette, C.A. & Flatow, J. (1988) Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide. Cancer, 62, 1275-1281.
80. Testa, S., Manna, A., Porcellini, A., Maffi, F., Morstabilini, G., Denti, N., Macchi, S., Rosti, G., Porcellini, G., Cassi, D, & Ferrari, L. (1996) Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation. Bone Marrow Transplantation, 18, 383-388.
81. Thaler, M., Pastiaka, B., Shawker, T.H., O'Leary, T. & Pizzo, P.A. (1988) Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Annals of Internal Medicine, 108, 88-100.
82. Ulutin, O.N. (1993) Antithrombotic effect and clinical potential of defibrotide. Seminars in Thrombosis and Hemostasis, 19, 186-191.
83. Watanabe, K., Iwaki, H., Satoh, M., Ikeda, T., Ichimiya, S., Suzuki, N., Kudoh, T., Oda, T., Matsuura, A., Mori, M. & Kituchi, K. (1996) Veno-occlusive disease of the liver following bone marrow transplantation: a clinical-pathological study of autopsy cases. Journal of Artifical Organs, 20, 1145-1150.
84. Zager, R.A., O'Quigley, J., Zager, B.K., Alpers, C.E., Shulman, H.M., Gamelin, L.M., Stewart, P. & Thomas, E.D. (1989) Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. American Journal of Kidney Diseases, 13, 210-216.
85. Zhou, Q., Chu, X. & Ruan, C. (1994) Defibrotide stimulates expression of thrombomodulin in human endothelial cells. Thrombosis and Hemostasis, 71, 507-510.
86. Zinke, W., Neumeister, P. & Linkesch, W. (1999) Defibrotide: an approach in the treatment of severe veno-occlusive disease? (Abstract). Bone Marrow Transplantation, 23, 760.